344 related articles for article (PubMed ID: 29258046)
1. Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocol.
Mohamed HE; Mohamed AA; Al-Ghobashy MA; Fathalla FA; Abbas SS
J Pharm Biomed Anal; 2018 Feb; 150():268-277. PubMed ID: 29258046
[TBL] [Abstract][Full Text] [Related]
2. Affinity profiling of monoclonal antibody and antibody-drug-conjugate preparations by coupled liquid chromatography-surface plasmon resonance biosensing.
Lakayan D; Haselberg R; Gahoual R; Somsen GW; Kool J
Anal Bioanal Chem; 2018 Dec; 410(30):7837-7848. PubMed ID: 30328504
[TBL] [Abstract][Full Text] [Related]
3. A mechanistic pharmacokinetic model elucidating the disposition of trastuzumab emtansine (T-DM1), an antibody-drug conjugate (ADC) for treatment of metastatic breast cancer.
Bender B; Leipold DD; Xu K; Shen BQ; Tibbitts J; Friberg LE
AAPS J; 2014 Sep; 16(5):994-1008. PubMed ID: 24917179
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the pattern and kinetics of degradation of adalimumab using a stability-indicating orthogonal testing protocol.
Hassan LA; Al-Ghobashy MA; Abbas SS
Biomed Chromatogr; 2019 Dec; 33(12):e4676. PubMed ID: 31389037
[TBL] [Abstract][Full Text] [Related]
5. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.
Marcoux J; Champion T; Colas O; Wagner-Rousset E; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
Protein Sci; 2015 Aug; 24(8):1210-23. PubMed ID: 25694334
[TBL] [Abstract][Full Text] [Related]
6. Biophysical Properties and Heating-Induced Aggregation of Lysine-Conjugated Antibody-Drug Conjugates.
Gandhi AV; Arlotta KJ; Chen HN; Owen SC; Carpenter JF
J Pharm Sci; 2018 Jul; 107(7):1858-1869. PubMed ID: 29626535
[TBL] [Abstract][Full Text] [Related]
7. Comparative Assessment of the Effect of Hyper-glycosylation on the Pattern and Kinetics of Degradation of Darbepoetin Alfa using a Stability-Indicating Orthogonal Testing Protocol.
Moenes EM; Al-Ghobashy MA; Mohamed AA; Salem MY
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():405-414. PubMed ID: 29157782
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of antibody-drug conjugates with high drug-to-antibody ratio using dimaleimide-DM1 as a linker- payload.
Jeon JH; Woo Kim S; Kim YJ; Park JW; Eun Moon J; Beom Lee Y; Yu H; Lee GH; Jin SH; Jeong JH
Bioorg Chem; 2024 Aug; 149():107504. PubMed ID: 38850783
[TBL] [Abstract][Full Text] [Related]
9. Stability assessment of Polatuzumab vedotin and Brentuximab vedotin using different analytical techniques.
Mohamed HE; Al-Ghobashy MA; Abbas SS; Boltia SA
J Pharm Biomed Anal; 2023 May; 228():115249. PubMed ID: 36827859
[TBL] [Abstract][Full Text] [Related]
10. In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate.
Chen L; Wang L; Shion H; Yu C; Yu YQ; Zhu L; Li M; Chen W; Gao K
MAbs; 2016 Oct; 8(7):1210-1223. PubMed ID: 27380163
[TBL] [Abstract][Full Text] [Related]
11. Improved Tumor Penetration and Single-Cell Targeting of Antibody-Drug Conjugates Increases Anticancer Efficacy and Host Survival.
Cilliers C; Menezes B; Nessler I; Linderman J; Thurber GM
Cancer Res; 2018 Feb; 78(3):758-768. PubMed ID: 29217763
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive stability assessment of insulin degludec using New customized validated RP-HPLC and SEC-HPLC methods in an orthogonal testing protocol.
Abdelwaly EA; Mohamed AA; El-Kosasy AM; Ayad MF
J Pharm Biomed Anal; 2021 Sep; 203():114175. PubMed ID: 34098506
[TBL] [Abstract][Full Text] [Related]
13. Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer.
Lambert JM; Chari RV
J Med Chem; 2014 Aug; 57(16):6949-64. PubMed ID: 24967516
[TBL] [Abstract][Full Text] [Related]
14. Correlation between Dynamic Light Scattering and Size Exclusion High Performance Liquid Chromatography for Monitoring the Effect of pH on Stability of Biopharmaceuticals.
Al-Ghobashy MA; Mostafa MM; Abed HS; Fathalla FA; Salem MY
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():1-9. PubMed ID: 28578190
[TBL] [Abstract][Full Text] [Related]
15. Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry.
Sang H; Lu G; Liu Y; Hu Q; Xing W; Cui D; Zhou F; Zhang J; Hao H; Wang G; Ye H
Anal Chim Acta; 2017 Feb; 955():67-78. PubMed ID: 28088282
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical stability of the antibody-drug conjugate Trastuzumab-DM1: changes due to modification and conjugation processes.
Wakankar AA; Feeney MB; Rivera J; Chen Y; Kim M; Sharma VK; Wang YJ
Bioconjug Chem; 2010 Sep; 21(9):1588-95. PubMed ID: 20698491
[TBL] [Abstract][Full Text] [Related]
17. Conjugation of Emtansine Onto Trastuzumab Promotes Aggregation of the Antibody-Drug Conjugate by Reducing Repulsive Electrostatic Interactions and Increasing Hydrophobic Interactions.
Gandhi AV; Randolph TW; Carpenter JF
J Pharm Sci; 2019 Jun; 108(6):1973-1983. PubMed ID: 30735687
[TBL] [Abstract][Full Text] [Related]
18. Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design.
Maass KF; Kulkarni C; Betts AM; Wittrup KD
AAPS J; 2016 May; 18(3):635-46. PubMed ID: 26912181
[TBL] [Abstract][Full Text] [Related]
19. Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer.
Junutula JR; Flagella KM; Graham RA; Parsons KL; Ha E; Raab H; Bhakta S; Nguyen T; Dugger DL; Li G; Mai E; Lewis Phillips GD; Hiraragi H; Fuji RN; Tibbitts J; Vandlen R; Spencer SD; Scheller RH; Polakis P; Sliwkowski MX
Clin Cancer Res; 2010 Oct; 16(19):4769-78. PubMed ID: 20805300
[TBL] [Abstract][Full Text] [Related]
20. Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
Ponte JF; Sun X; Yoder NC; Fishkin N; Laleau R; Coccia J; Lanieri L; Bogalhas M; Wang L; Wilhelm S; Widdison W; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
Bioconjug Chem; 2016 Jul; 27(7):1588-98. PubMed ID: 27174129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
